Questions 31–40

  • Yousaf Ali


This chapter illustrates a variety of different scenarios of rheumatic disease in succinct question and answer format. It contains ten complex cases with potentially unusual diagnoses designed to stimulate thought and further reading in this rapidly evolving specialty.


Assessment of rheumatic diseases Complex rheumatology cases Rare rheumatic diseases Rheumatology board exam preparation Rheumatology case studies Study guide for rheumatology 


  1. 1.
    Pedersen-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin’s lymphoma. N Engl J Med. 1988;318:1028–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Monach PA, Arnold LM, Merkel PA. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum. 2010;62(1):9–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Owens RE, Swanson H, Twilla JD. Hemolytic anemia induced by pegloticase infusion in a patient with G6PD deficiency. J Clin Rheumatol. 2016;22(2):97–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Geraldino-Pardilla L, Sung D, Xu JZ, et al. Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result. Rheumatology. 2014;53(12):2310–1.CrossRefPubMedGoogle Scholar
  5. 5.
    Sonbol MB, Yadav H, Vaidya R, Rana V, Witzig TE. Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase. Am J Hematol. 2013;88(2):152–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Boyd AD Jr, Thornhill TS. Surgical treatment of osteoarthritis of the shoulder. Rheum Dis Clin N Am. 1988;14:591.Google Scholar
  7. 7.
    Rispoli DM, Sperling JW, Athwal GS, et al. Humeral head replacement for the treatment of osteoarthritis. J Bone Joint Surg Am. 2006;88:2637.CrossRefPubMedGoogle Scholar
  8. 8.
    Md N, Kalthum U, Zahidin AZA, Yong TK. Retinal vasculitis in systemic lupus erythematosus: an indication of active disease. Clin Pract. 2012;2(2):e54.CrossRefGoogle Scholar
  9. 9.
    Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65:549–60. Scholar
  10. 10.
    Berkun Y, et al. A man with swollen calf and discoloration of the foot. Postgrad Med J. 2002;78:304.CrossRefGoogle Scholar
  11. 11.
    Kraag G, Thevathasan EM, Gordon DA, Walker IH. The hemorrhagic crescent sign of acute synovial rupture. Ann Intern Med. 1976;85:477.CrossRefPubMedGoogle Scholar
  12. 12.
    Puri PK, Lountzis NI, Tyler W, Ferringer T. Hydroxychloroquine-induced hyperpigmentation: the staining pattern. J Cutan Pathol. 2008;35(12):1134–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498–509.CrossRefGoogle Scholar
  14. 14.
    Karavidas MK, Tsai PS, Yucha C, McGrady A, Lehrer PM. Thermal biofeedback for primary Raynaud’s phenomenon: a review of the literature. Appl Psychophysiol Biofeedback. 2006;31(3):203–16.CrossRefPubMedGoogle Scholar
  15. 15.
    Orbai A-M, Weitz J, Siegel EL, et al. Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis. J Rheumatol. 2014;41:2290–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Rose S, Toloza S, Bautista-Molano W, et al. GRAPPA Dactylitis Study Group. Comprehensive treatment of dactylitis in psoriatic arthritis. J Rheumatol. 2014;41:2295–300.CrossRefPubMedGoogle Scholar
  17. 17.
    Richert B, Caucanas M, André J. Diagnosis using nail matrix. Dermatol Clin. 2015;33(2):243–55.CrossRefPubMedGoogle Scholar
  18. 18.
    Clark EM, Durup D. Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks? Ther Adv Musculoskelet Dis. 2015;7(1):11–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever Jones criteria. JAMA. 1992;268(15):2069–73.CrossRefGoogle Scholar
  20. 20.
    Gewitz MH, Baltimore RS, Tani LY, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015;131(20):1806–18.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Yousaf Ali
    • 1
  1. 1.Mount Sinai HospitalNew YorkUSA

Personalised recommendations